KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Castle Biosciences (CSTL) Shares Outstanding (2018 - 2023)

Historic Shares Outstanding for Castle Biosciences (CSTL) over the last 6 years, with Q2 2023 value amounting to $26.8 million.

  • Castle Biosciences' Shares Outstanding rose 187.02% to $26.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $26.8 million, marking a year-over-year increase of 187.02%. This contributed to the annual value of $26.6 million for FY2022, which is 463.05% up from last year.
  • According to the latest figures from Q2 2023, Castle Biosciences' Shares Outstanding is $26.8 million, which was up 187.02% from $26.7 million recorded in Q1 2023.
  • In the past 5 years, Castle Biosciences' Shares Outstanding registered a high of $26.8 million during Q2 2023, and its lowest value of $1.9 million during Q1 2019.
  • Moreover, its 5-year median value for Shares Outstanding was $25.1 million (2021), whereas its average is $21.0 million.
  • Per our database at Business Quant, Castle Biosciences' Shares Outstanding surged by 79755.76% in 2020 and then surged by 171.99% in 2022.
  • Quarter analysis of 5 years shows Castle Biosciences' Shares Outstanding stood at $17.1 million in 2019, then soared by 44.84% to $24.8 million in 2020, then rose by 2.28% to $25.4 million in 2021, then increased by 4.63% to $26.6 million in 2022, then grew by 0.87% to $26.8 million in 2023.
  • Its Shares Outstanding was $26.8 million in Q2 2023, compared to $26.7 million in Q1 2023 and $26.6 million in Q4 2022.